ChitogenX Inc. (CSE:CHGX)
0.0050
0.00 (0.00%)
Jun 10, 2025, 9:04 AM EDT
ChitogenX Market Cap
ChitogenX has a market cap or net worth of CAD 415.65 thousand as of November 20, 2026. It is the 50,805th most valuable company in the world and the 2,656th biggest in Canada. Its market cap has decreased by 83.33% in one year.
Market Cap
415.65K
Enterprise Value
4.60M
Revenue
n/a
Global Rank
Country Rank
#2,656 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since October 10, 2017, ChitogenX's market cap has decreased from 18.46M to 415.65K, a decrease of -97.75%. That is a compound annual growth rate of -39.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2025 | 415.65K | -66.67% |
| Dec 30, 2024 | 1.25M | -76.92% |
| Dec 29, 2023 | 5.40M | -59.28% |
| Dec 30, 2022 | 13.27M | 15.04% |
| Dec 31, 2021 | 11.54M | -49.27% |
| Dec 31, 2020 | 22.74M | 337.46% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quest PharmaTech | 3.38M |
| Grey Matters Health | 3.33M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 1.59M |
| Universal Ibogaine | 1.56M |
| MindBio Therapeutics | 655.48K |
| Doseology Sciences | 640.93K |
| Waverley Pharma | 540.00K |